Vanguard Capital Management’s Arcadia Biosciences RKDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.7K Hold
9,644
– – ﹤0.01% 4052
2026
Q2
$6.55K Hold
9,644
– – ﹤0.01% 4062
2026
Q1
$13.3K Buy
+9,644
New +$18.9K ﹤0.01% 4002

Other funds holding RKDA

Vanguard Capital Management's RKDA Position: Q3 2026 in Review

Vanguard Capital Management held its Arcadia Biosciences (RKDA) position steady in Q3 2026 at 9,644 shares worth $2.7K. The position accounts for ﹤0.01% of the portfolio, ranked #4052.

Vanguard Capital Management first reported a position in RKDA in Q1 2026 and has held it in 3 quarters since. The position peaked at $13.3K in Q1 2026. 19 funds tracked by Wall St. Rank hold RKDA as of Q3 2026.

  • Vanguard Capital Management held 9,644 shares of Arcadia Biosciences worth $2.7K as of Q3 2026.
  • Vanguard Capital Management left its Arcadia Biosciences share count unchanged in Q3 2026.
  • Arcadia Biosciences made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #4052 holding.
  • Vanguard Capital Management first reported a position in Arcadia Biosciences in Q1 2026 and has held it in 3 quarters since.
  • Vanguard Capital Management's Arcadia Biosciences position peaked at $13.3K in Q1 2026.
  • 19 funds tracked by Wall St. Rank held Arcadia Biosciences as of Q3 2026.

Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.